Ting Gootee

A statewide association of technology-driven companies, raising the profile of Indiana's fastest growing sector.

On Target Laboratories discovers and develops targeted intraoperative molecular imaging agents to illuminate cancer during surgery so cancerous tissue can be removed more completely. To date, there has been no reliable way for surgeons to assess the location and full extent of cancerous tissue while operating. Our molecular imaging technology, based on the pioneering work of Philip S. Low, PhD, Purdue Universitys Presidential Scholar for Drug Discovery and the Ralph C. Corley Distinguished Professor of Chemistry, aims to reduce the uncertainty associated with finding and removing cancerous tissue during surgical procedures, helping surgeons to provide a more precise and complete surgical resection. Visit our website to learn more about On Target Laboratories and our targeted intraoperative molecular imaging agents.

Sharpen is a cloud-native contact center platform that helps companies create perfect customer experiences. Our contact center software is ideal for mid-size to enterprise businesses. Designed for agent productivity and efficiency, it's the perfect solution for both customer support and outbound sales teams. Our motivation is simple - everything we do must improve the life of the agent, and in turn, improve the customer experience.

Imagine a world where every healthcare and benefits program decision is backed and guided by data. Springbuk is the health data analytics solution that equips you with the insights and expertise you need to sharpen your benefits strategy, advance employee health, and contain costs. Unlike legacy data warehouses, we simplify data-driven decision-making with an intuitive user experience, predictive modeling, and curated action steps. Springbuk — a world of actionable health intelligence insight, at your fingertips. Visit springbuk.com to learn more.

hc1 is the leader in critical insight, analytics, and solutions for precision health. The cloud-based hc1 Platform organizes volumes of live data, including lab results, genomics, and medications, to deliver solutions that ensure that the right patient gets the right test and the right prescription. Today, the hc1 Platform powers solutions that optimize diagnostic testing and prescribing for millions of patients nationally. To learn more about hc1's proven approach to personalizing care while eliminating waste for thousands of health systems, diagnostic laboratories, and health plans, visit www.hc1.com.

Our firm combines primary research, technology, and a proven customer strategy model to find the best solutions to our clients’ most challenging questions. Unlike traditional market research, our team of experts collects and delivers customer insights in record time so that you can swiftly and confidently make strategic decisions that win customer choice. Vennli does not do market research. We deliver quick and agile insights that give you fast answers to key questions like: How do our customers view us vs. our competition? What do our customers want most in our product? What are their perceptions of price? How strong is our messaging and/or branding? Does it resonate with our customers? Who are our prospective customers, what do they believe, and how do we reach them?

AIT Bioscience is now a part of @Nexelis! Joining Nexelis, the next generation of specialty testing labs for small and large molecules, our portfolio expands to meet your specific development stage and service area needs. AIT Bioscience brings bioanalytical LC/MS and ligand binding platforms along with state-of-the-art electronic laboratory notebook (ELN) to the Nexelis’ portfolio to help sponsors of all company sizes and therapeutic areas.

Private Securities. Investment Banking. Over $15 Billion in Recent Transactions. A global leader in private stock liquidity solutions for institutional investors. FNEX provides institutional access and liquidity solutions to a global market of leading private companies.

On March 2, 2015 Proofpoint announced that they have signed a definitive to acquire Emerging Threats. Emerging Threats is a world-leading provider of commercial and open source threat intelligence. Founded in 2003 as a cyber security research community, Emerging Threats has become the de facto standard in network-based malware threat detection. The company’s IQRisk® Suite of threat intelligence products delivers time-tested, comprehensive actionable data with historical, correlated threat intelligence to support context for the latest malware coverage and in-depth threat analysis. IQRisk Suite combines IQRisk Query, IQRisk Rep List, and the ETPro® Ruleset to provide the highest level of timely and accurate threat intelligence and prevention to protect networks from data exfiltration and a wide variety of malicious threats that include exploits and malware. Used by many G2000 companies, Emerging Threats products and solutions are easy-to-deploy, making them ideal for OEMs, enterprises, government agencies, financial institutions, SMBs, higher education, and managed service providers.

SonarMed, Inc. is an Indianapolis-based start-up company focused on the respiratory care space.

Elevate Ventures invests in high-potential cross-sector innovative companies with a minimum $500M TAM at the pre-seed, seed, and early stages. Over the last 10+ years, Elevate has invested capital in more than 500 Indiana-based startups and provided assistance to nearly 4,000 companies across 86 counties. We are the #1 Most Active Seed & Early-Stage Venture Capital Firm in the Great Lakes Region. The foundation is set for an even more impactful 10 years ahead with Indiana’s potential to become the Innovation Capital of the World®. To drive our state closer to this vision, Elevate focuses on three areas: • Community: Build Collaborative Communities • Capital: Invest in High-Potential Companies • Acceleration: Provide World-Class Programming Learn more at https://elevateventures.com

The Central Indiana Corporate Partnership (CICP) was formed in 1999 to bring together the chief executives of Central Indiana’s prominent corporations, foundations and universities in a strategic and collaborative effort dedicated to the regions continued prosperity and growth. To advance this mission, CICP sponsors five key talent and industry sector initiatives, AgriNovus Indiana, Ascend Indiana, BioCrossroads, Conexus Indiana and TechPoint, each of which addresses challenges and opportunities unique to its respective area: agbiosciences, talent and workforce development, life sciences, advanced manufacturing and logistics and technology.

We invest to generate significant and long-lasting social and economic impact for IU, Indiana, and the World.

A statewide association of technology-driven companies, raising the profile of Indiana's fastest growing sector.

Scale Computing is a leader in edge computing, virtualization, and hyperconverged solutions for customers around the globe. Scale Computing HyperCore software eliminates the need for traditional virtualization software, disaster recovery software, servers, and shared storage, replacing these with a fully integrated, highly available system for running applications. The Scale Computing self-healing platform automatically identifies, mitigates, and corrects problems in the infrastructure in real-time, enabling applications to achieve maximum uptime even when local IT resources and staff are scarce. This innovation makes Scale Computing Platform simple for IT to manage and administer. When ease-of-use, high availability, and TCO matter, Scale Computing is the ideal infrastructure platform for distributed enterprises, global retailers, and SMBs alike.